Urinary retention
Adult: 10-50 mg 3-4 times daily.
Indications and Dosage
Oral
Urinary retention Adult: 10-50 mg 3-4 times daily.
|
Administration
Should be taken on an empty stomach. Take 1 hr before or 2 hr after meals.
|
Contraindications
Intestinal or urinary obstruction, recent MI, pronounced bradycardia or hypotension, recent intestinal anastomosis, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, vasomotor instability, coronary artery disease, epilepsy, parkinsonism. Lactation.
|
Special Precautions
Pregnancy.
|
Adverse Reactions
Nausea, vomiting, sweating, intestinal colic, malaise, abdominal cramps or discomfort, belching, diarrhoea, borborygmi, salivation, urinary urgency, headache, hypotension, vasomotor response, hot flushes, sweating, lachrymation, miosis, seizure, reflux infection.
|
Parenteral/PO/SC: C
|
Patient Counseling Information
May impair ability to drive or operate machinery.
|
Monitoring Parameters
Assess bladder and sphincter adequacy prior to therapy.
|
Overdosage
Symptoms: Nausea, salivation, lachrymation, eructation, involuntary defecation and urination, transient dyspnoea, palpitation, bradycardia, peripheral vasodilation leading to HTN, transient heart block and feeling of constriction under sternum. Management: Perform gastric lavage and aspiration. Administer atropine sulfate 1-2 mg IV, IM or SC 2-4 hrly as necessary, to control muscarinic effects. Supportive treatment may include IV diazepam 5-10 mg; tubocurarine (w/ assisted respiration, to control muscle twitching); oxygen may be required.
|
Drug Interactions
Atropine, quinidine, procainamide, epinephrine and other sympathomimetic amines may antagonise the effect of bethanechol. Critical fall in blood pressure, usually preceded by severe abdominal symptoms, may occur when used w/ ganglionic blocking agents. Additive effects and increased toxicity w/ other cholinergic drugs or anticholinesterase agents (e.g. neostigmine).
|
Action
Description: Bethanechol acts primarily by stimulating parasympathetic nervous system, hence releasing acetylcholine at the nerve endings. It increases the tone of detrusor urinary muscle, producing a contraction to initiate urination. It also stimulates gastric motility, restores impaired rhythmic peristalsis and increases gastric tone.
Onset: 30-90 min. Duration: Approx 1 hr. Pharmacokinetics: Absorption: Poorly absorbed from the GI tract. |
Chemical Structure
![]() Source: National Center for Biotechnology Information. PubChem Database. Bethanechol, CID=2370, https://pubchem.ncbi.nlm.nih.gov/compound/Bethanechol (accessed on Jan. 21, 2020) |
Storage
Store between 20-25°C.
|
ATC Classification
N07AB02 - bethanechol ; Belongs to the class of choline esters. Used as parasympathomimetics.
|
References
Anon. Bethanechol. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 18/08/2016. Bethanechol chloride Tablet (Pliva Inc). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 18/08/2016. Buckingham R (ed). Bethanechol chloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 18/08/2016. Joint Formulary Committee. Bethanechol chloride. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 18/08/2016. McEvoy GK, Snow EK, Miller J et al (eds). Bethanechol Chloride. AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 18/08/2016. Myotonine 10 mg Tablets (Glenwood GmbH). eMC. https://www.medicines.org.uk/emc/. Accessed 18/08/2016.
|